(MSOS) AdvisorShares Pure US - Overview

ETF Category: Miscellaneous Sector | Exchange: NYSE ARCA (USA) | Market Cap: 953m USD | Total Return: 99.2% in 12m

Cannabis, Hemp, Pharmaceuticals, Biotechnology, Life Sciences
Total Rating 66
Safety 69
Buy Signal -0.31
Miscellaneous Sector
Category Rotation: -2.6
TER: 0.83%
AUM: 953M
Avg Turnover: 29.9M
Risk 3d forecast
Volatility83.1%
VaR 5th Pctl13.0%
VaR vs Median-13.3%
Reward TTM
Sharpe Ratio1.10
Rel. Str. IBD82.2
Rel. Str. Peer Group41.2
Character TTM
Beta0.853
Beta Downside0.461
Hurst Exponent0.416
Drawdowns 3y
Max DD81.71%
CAGR/Max DD-0.06
CAGR/Mean DD-0.12

Warnings

Choppy

Tailwinds

No distinct edge detected

Description: MSOS AdvisorShares Pure US

The AdvisorShares Pure US Cannabis ETF (MSOS) is an actively managed fund targeting U.S.-based companies within the marijuana and hemp industries. To qualify for inclusion, holdings must derive a minimum of 50% of their net revenue from these sectors, with at least 80% of the funds total assets allocated to such securities or related derivatives. The fund maintains a concentrated position in the healthcare sector, specifically within pharmaceuticals and biotechnology.

Because cannabis remains classified as a Schedule I substance under the federal Controlled Substances Act, U.S. multi-state operators (MSOs) cannot list directly on major domestic exchanges like the NYSE or Nasdaq. Consequently, this ETF utilizes total return swaps to gain economic exposure to these companies, which primarily trade on the Canadian Securities Exchange or over-the-counter markets. Investors often monitor legislative developments, such as potential rescheduling or banking reform, as primary catalysts for the sectors valuation. Detailed fundamental metrics for these holdings are available on ValueRay for those conducting further due diligence.

Headlines to Watch Out For
  • Federal rescheduling of cannabis from Schedule I to Schedule III reduces tax burdens
  • SAFER Banking Act passage improves institutional capital access and lowers cost of debt
  • Expansion of adult-use recreational markets in major states drives multi-state operator revenue
  • High interest rates and limited liquidity strain balance sheets of non-diversified holdings
  • Federal legalization progress dictates volatility for derivative-based exposure to US cannabis operators
What is the price of MSOS shares?

As of June 04, 2026, the stock is trading at USD 4.74 with a total of 9,917,629 shares traded.
Over the past week, the price has changed by +1.94%, over one month by -2.07%, over three months by +26.06% and over the past year by +99.16%.

Is MSOS a buy, sell or hold?

AdvisorShares Pure US has no consensus analysts rating.